Pfizer and BioNTech Conclude Phase 3 Study of COVID-19 Vaccine Candidate, Meeting All Primary Efficacy Endpoints

by admin | Nov 18, 2020 | Breaking News Express-SR

160730960632937_P9159954

Sorry, this entry is only available in 中文.

類型: 連結
出處: Business Wire
連結: https://www.businesswire.com/news/home/20201118005595/en/Pfizer-and-BioNTech-Conclude-Phase-3-Study-of-COVID-19-Vaccine-Candidate-Meeting-All-Primary-Efficacy-Endpoints

← →